Browsing by Author "Maselli A."

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Musculoskeletal manifestations in children with Behçet’s syndrome: data from the AIDA Network Behçet’s Syndrome Registry
    (Springer Science and Business Media Deutschland GmbH, 2023) Gaggiano C.; Maselli A.; Sfikakis P.P.; Laskari K.; Ragab G.; Hegazy M.T.; Laymouna A.H.; Lopalco G.; Almaghlouth I.A.; Asfina K.N.; Alahmed O.; Giardini Mayrink H.A.; Parente de Brito Antonelli I.; Cattalini M.; Piga M.; Sota J.; Gentileschi S.; Maggio M.C.; Opris-Belinski D.; Hatemi G.; Insalaco A.; Olivieri A.N.; Tufan A.; Karadeniz H.; Kardaş R.C.; La Torre F.; Cardinale F.; Marino A.; Guerriero S.; Ruscitti P.; Tarsia M.; Vitale A.; Caggiano V.; Telesca S.; Iannone F.; Parretti V.; Frassi M.; Aragona E.; Ciccia F.; Wiesik-Szewczyk E.; Ionescu R.; Şahin A.; Akkoç N.; Hinojosa-Azaola A.; Tharwat S.; Hernández-Rodríguez J.; Espinosa G.; Conti G.; Del Giudice E.; Govoni M.; Emmi G.; Fabiani C.; Balistreri A.; Frediani B.; Rigante D.; Cantarini L.
    This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefficacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p = 0.46) or the concomitant therapy (p = 0.30 for cDMARDs, p = 1.00 for glucocorticoids); cDMARDs and bDMARDs were inefficacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefficacy (p = 0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively affects response to biologic therapies. ClinicalTrials.gov Identifier: NCT05200715 (registered on December 18, 2021). © 2023, The Author(s).